Translational rewiring downstream of oncogenic signaling (e.g., RAS/RAF/MEK/ERK, PI3K/AKT/mTOR, Wnt/β-catenin) is a key adaptive mechanism in cancer cells that allows specific changes in the proteome to support tumor development, metastasis, and treatment resistance (1, 3). The gene discussed is MTOR; the disease is neoplasm.